Consumer Defensive
Natural Beauty Bio-Technology Limited(NBBTF)
Live Price
Offline$0.061
+0.00% today
1Y Change
+15.09%
Window
Jun 25, 2025 โ Jun 23, 2026
- Market Cap
- $950.00M
- Revenue Growth
- +52.3%
- EPS Growth
- +110.4%
- Dividend Yield
- 0.0%
Coverage: 249 bars ยท Jun 25, 2025 โ Jun 23, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Natural Beauty Bio-Technology Limited (NBBTF) is a Consumer Defensive stock with a market cap of $950.00M and listed on OTC. The stock last traded around $0.06 and up 15.1% across the available one-year price window (Jun 25, 2025 โ Jun 23, 2026). Baseline metrics include revenue growth of +52.3%, EPS growth of +110.4%, a dividend yield of 0.0%. What stands out right now is revenue +52.3%, EPS +110.4%, free cash flow -70.8% with operating margin 3.3% and ROIC 2.0%. Valuation already assumes a fairly strong business story at P/E 89.9 and price/sales 1.8. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines NBBTF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+52.3% vs +1.7% peer median
Operating Margin
Below sector median
+3.3% vs +6.6% peer median
P/E
Above sector median
89.9 vs 14.0 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2025 was reported on Dec 31, 2025, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +52.3% and EPS at +110.4%, with operating margin around 3.3%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2025 Dec 31, 2025 | โ | +0.0% | +0.0% | +0.0% |
2025 May 23, 2025 | โ | +0.0% | +0.0% | +0.0% |
2025 Feb 24, 2025 | โ | +0.0% | +0.0% | +0.0% |
Benchmark Edge
NBBTF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
NBBTF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
NBBTF Max Drawdown
-47.92%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for NBBTF and SPY.
Company Overview
Natural Beauty Bio-Technology Limited
Other OTC
Natural Beauty Bio-Technology Limited, an investment holding company, offers skin care products and services in in the People's Republic of China, Taiwan, and internationally. The company manufactures and sells skin care, beauty, aroma-therapeutic, cosmetics, health supplements, and make-up products under the Natural Beauty brand. It also offers skin treatment, beauty and spa, medical cosmetology, skin care consulting, and beauty consulting and training services. In addition, the company's spas provide hydrotherapy, facial treatment, body care, and skin care analysis services. Further, it engages in the wholesale of skin care and beauty products. The company was founded in 1976 and is based in Wan Chai, Hong Kong.
- Leadership
- Chi Chung Cheng
- IPO Date
- Feb 3, 2012
- Employees
- 542
- Street Address
- Hopewell Centre
- Mailing
- Wan Chai
- Region
- Wan Chai, HK
- Reporting Currency
- USD
- Investor Line
- +852 2366 1121
- Last Updated
- May 2, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 89.9
- EV/EBITDA
- 20.6
- Price/Sales
- 1.8
- Price/Book
- 2.0
Growth
- Revenue
- +52.3%
- EPS
- +110.4%
- Free Cash Flow
- -70.8%
Profitability
- Gross Margin
- 50.0%
- Operating Margin
- 3.3%
- Net Margin
- 2.0%
- ROE
- 2.2%
- ROIC
- 2.0%
Balance Sheet
- Debt/Equity
- 0.67
- Current Ratio
- 1.11
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.